PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan

Invesco S&P World Health Care ESG UCITS ETF Acc (WH2E.DE) Sharpe Ratio: 0.68

ETF · Currency in EUR · Last updated Jun 5, 2026

WH2E.DE is a passive ETF by Invesco tracking the investment results of the S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care. WH2E.DE launched on Apr 12, 2023 and has a 0.18% expense ratio.

WH2E.DE's Sharpe Ratio of 0.68 indicates that for each unit of volatility, it generates 0.68 units of excess return above the risk-free rate. The ratio is calculated using historical daily returns over the past 12 months (as of Jun 5, 2026).

Sharpe uses total volatility (standard deviation) which includes both upside and downside price movements, making it useful for comparing risk-adjusted returns across different assets.

WH2E.DE Sharpe Ratio Rank

WH2E.DE Sharpe Ratio Rank: 20.721
Below Average

WH2E.DE ranks above 20.7% of all investments in our database based on Sharpe Ratio over the past 12 months, indicating below-average returns relative to volatility. Securities are ranked from 0 (worst) to 100 (best).

What moves the rank

  • Strong returns with low total volatility → Higher rank
  • High volatility (both upside and downside) → Lower rank
  • Consistent returns → Higher rank than volatile returns of same magnitude
  • Sharp drawdowns increase volatility → Lower rank

What you can do with this information

  • Returns may not adequately compensate for volatility taken
  • Consider smaller allocation given below-average risk-adjusted profile
  • Explore higher-ranked investments with better consistency
  • Assess whether the volatility profile aligns with your portfolio goals

WH2E.DE Sharpe Ratio Market Positioning

The chart shows WH2E.DE's Sharpe Ratio relative to all ETFs on our platform, with color zones indicating percentile rankings. Higher ratios indicate better risk-adjusted returns.

  • Red zone (bottom 25%): 0.85 or lower
  • Yellow zone (middle 50%): 0.85 to 2.39
  • Green zone (top 25%): 2.39 or higher
  • Top 1%: 7.60+
  • Median: 1.70 — half of all investments score higher

How it compares to other similar ETFs

The table compares Invesco S&P World Health Care ESG UCITS ETF Acc's Sharpe Ratio with other ETFs in the Health & Biotech Equities category across multiple time periods, showing how WH2E.DE's risk-adjusted performance compares to similar funds.

Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jun 5, 2026.

SymbolName1Y Sharpe Ratio5Y Sharpe Ratio10Y Sharpe RatioAll Time Sharpe Ratio
2B70.DEiShares Nasdaq US Biotechnology UCITS ETF2.04
NBTK.DEInvesco Nasdaq Biotech UCITS ETF2.03
GN0M.DEGlobal X Genomics & Biotechnology UCITS ETF2.00
WRNA.DEWisdomTree BioRevolution UCITS ETF USD Acc1.75
2B77.DEiShares Ageing Population UCITS ETF1.36
XGEN.DEXtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C1.23
ETLI.DEL&G Pharma Breakthrough UCITS ETF1.16
2B78.DEiShares Healthcare Innovation UCITS ETF0.95
ZPDH.DESPDR S&P US Health Care Select Sector UCITS ETF0.89
QDVG.DEiShares S&P 500 Health Care Sector UCITS ETF (Acc)0.89
WH2E.DEInvesco S&P World Health Care ESG UCITS ETF Acc0.68

S&P 500 Index

How to choose period

Historical Sharpe Ratio

The chart shows WH2E.DE's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when WH2E.DE consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sharpe Ratio Calculator

How does WH2E.DE fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio